Skip to Main Content

Paper Details

Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
Stroke
275
2016
Author NameAffiliation
Lawrence R WechslerStanford University School of Medicine and Stanford Health Care, New York University and NYU Langone Medical Center, University of Pittsburgh Medical School and University of Pittsburgh Medical Center, University of California san francisco
  • 1 - 1

Datasets